MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
30.27
-0.04 (-0.13%)
Apr 29, 2026, 11:30 AM EDT - Market open
MapLight Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -161.15 | -77.58 | -55.71 | -30.02 |
| Depreciation & Amortization | 0.58 | 0.7 | 0.56 | 0.57 |
| Loss (Gain) From Sale of Assets | 0.01 | 0.06 | - | - |
| Loss (Gain) From Sale of Investments | -2.1 | -1.74 | 0.51 | -0.8 |
| Loss (Gain) on Equity Investments | - | 0.99 | -0.99 | - |
| Stock-Based Compensation | 36.01 | 1.08 | 1.05 | 1.36 |
| Other Operating Activities | 1.36 | 0.75 | 0.53 | 0.57 |
| Change in Accounts Payable | 1.38 | -1.35 | -0.41 | 1.33 |
| Change in Unearned Revenue | -3.24 | -0.96 | -1.66 | 1.86 |
| Change in Other Net Operating Assets | -10.98 | -0.76 | 4.11 | -1.46 |
| Operating Cash Flow | -138.14 | -78.82 | -52.01 | -26.58 |
| Capital Expenditures | -0.47 | -0.77 | -0.46 | -0.75 |
| Investment in Securities | -322.73 | -80.02 | - | - |
| Investing Cash Flow | -323.21 | -80.79 | -0.46 | -0.75 |
| Issuance of Common Stock | 276 | 0.29 | 0.04 | 0.01 |
| Other Financing Activities | -5.02 | -2.19 | - | -0.02 |
| Financing Cash Flow | 469.82 | 118.06 | 104.57 | 33.18 |
| Net Cash Flow | 8.48 | -41.54 | 52.1 | 5.85 |
| Free Cash Flow | -138.61 | -79.59 | -52.47 | -27.32 |
| Free Cash Flow Per Share | -15.97 | -108.11 | -79.54 | -49.05 |
| Levered Free Cash Flow | -83.13 | -51.86 | -32.18 | - |
| Unlevered Free Cash Flow | -83.13 | -51.86 | -32.18 | - |
| Change in Working Capital | -12.84 | -3.07 | 2.04 | 1.72 |
Source: S&P Capital IQ. Standard template.
Financial Sources.